|
ESC CONGRESS 2019
31 August - 04 September 2019, Paris - France
Session Details
|
Insight into atrial physiology and pathology
|
Sun 01 Sep
|
10:05 - 10:55
|
Basic Science - Cardiac Diseases: Arrhythmias
|
Moderated Posters, Abstract-based Programme
|
Moderated ePoster 3 - Poster Area
|
Chairpersons: Natasja DE GROOT (Rotterdam, Netherlands (The)), Dobromir DOBREV (Essen, Germany)
|
Learning Objectives: Moderated Posters are on display from 08:30 to 11:30 on the plasma screen of the topic related Moderated Poster station.
During the moderated poster session (10:05-10:55), from a large plasma screen, Presenters will summarise their research within 3 minutes and then address questions from the Chairpersons and Audience.
|
Other resources
List of Presentations
Loading...
10:05 | P1229 | Massive expansion of native human atrial cardiomyocytes through immortogenetics: generation of the hiAM cell lines | Niels HARLAAR (Leiden, Netherlands (The)) |
|
10:05 | P1230 | Impact of regulated junctophilin-2 clustering at axial tubule junctions on atrial excitation-contraction coupling and therapeutic implications | Soeren BRANDENBURG (Goettingen, Germany) |
|
10:05 | P1231 | Loss of function in cytoskeletal genes associates with early onset atrial fibrillation | Oliver Bundgaard VAD (Copenhagen, Denmark) |
|
10:05 | P1232 | A subpopulation of epicardium-derived cells are preprogrammed towards fibroblast differentiation in the atrial myocardium | Nadine SUFFEE (Paris, France) |
|
10:05 | P1233 | Differential effects of five risk variants for atrial fibrillation at the 4q25 region on L-type calcium current and transient inward currents in human atrial myocytes | Carmen TARIFA (Barcelona, Spain) |
|
10:05 | P1234 | Weight fluctuation demonstrates residual atrial arrhythmogenic substrate despite final weight loss in a chronic sheep model: implications for epicardial fat and fibrofatty infiltrates | Thomas Adam AGBAEDENG (Adelaide, Australia) |
|
10:05 | P1235 | Acetylcholine-activated inward-rectifier potassium currents in atrial cardiomyocytes derived from induced pluripotent stem cells and atrial engineered heart muscle preparations | Robin SPRINGER (Goettingen, Germany) |
|
|
|
|